Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI North America CPhI North America
Not Confirmed
Not Confirmed
20-22 May, 2025
Not Confirmed
Not Confirmed
22-25 April, 2025
AACR Annual meetingAACR Annual meeting
Not Confirmed
Not Confirmed
25-30 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
Industry Trade Show
Not Confirmed
22-25 April, 2025
AACR Annual meetingAACR Annual meeting
Industry Trade Show
Not Confirmed
25-30 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/top-pharma-companies-drugs-in-2024-merck-s-keytruda-maintains-top-spot-as-novo-s-semaglutide-nips-at-its-heels
13 Mar 2025
// PRESS RELEASE
https://viivhealthcare.com/hiv-news-and-media/news/press-releases/2025/march/investigational-broadly-neutralising-antibody/
12 Mar 2025
// BUSINESSWIRE
24 Jan 2025
// ECONOMICTIMES
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-gets-usfda-nod-for-generic-hiv-drug/articleshow/117517932.cms
11 Nov 2024
// BUSINESSWIRE
07 Nov 2024
// BUSINESSWIRE
16 Oct 2024
// BUSINESSWIRE
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : SOLUTION
Dosage Strength : 20MG/ML
Packaging : 240 ML
Brand Name : ZIAGEN
Approval Date :
Application Number : 2240358
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : TABLET
Dosage Strength : 600MG
Packaging : 30
Brand Name : TRIUMEQ
Approval Date :
Application Number : 2430932
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : TABLET
Dosage Strength : 600MG
Packaging : 30
Brand Name : KIVEXA
Approval Date :
Application Number : 2269341
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : SUSPENSION (EXTENDED-RELEASE)
Dosage Strength : 200MG/ML
Packaging :
Brand Name : CABENUVA
Approval Date :
Application Number : 2497220
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : SUSPENSION (EXTENDED-RELEASE)
Dosage Strength : 200MG/ML
Packaging :
Brand Name : CABENUVA
Approval Date :
Application Number : 2497247
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : SUSPENSION (EXTENDED-RELEASE)
Dosage Strength : 200MG/ML
Packaging :
Brand Name : APRETUDE
Approval Date :
Application Number : 2547473
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
CABOTEGRAVIR (CABOTEGRAVIR SODIUM)
Dosage Form : TABLET
Dosage Strength : 30MG
Packaging :
Brand Name : VOCABRIA
Approval Date :
Application Number : 2497204
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
CABOTEGRAVIR (CABOTEGRAVIR SODIUM)
Dosage Form : TABLET
Dosage Strength : 30MG
Packaging :
Brand Name : APRETUDE
Approval Date :
Application Number : 2547465
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM)
Dosage Form : TABLET
Dosage Strength : 50MG
Packaging :
Brand Name : DOVATO
Approval Date :
Application Number : 2491753
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM)
Dosage Form : TABLET
Dosage Strength : 50MG
Packaging : 30
Brand Name : TIVICAY
Approval Date :
Application Number : 2414945
Regulatory Info : Prescription
Registration Country : Canada
ABOUT THIS PAGE